ZENG Yan, ZHANG Li, SHEN Hong, WANG Yong. Clinical value of serum homocysteine, cystatin C, urinary albumin and urinary β2 microglobulin in diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 109-112. DOI: 10.7619/jcmp.201911031
Citation: ZENG Yan, ZHANG Li, SHEN Hong, WANG Yong. Clinical value of serum homocysteine, cystatin C, urinary albumin and urinary β2 microglobulin in diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 109-112. DOI: 10.7619/jcmp.201911031

Clinical value of serum homocysteine, cystatin C, urinary albumin and urinary β2 microglobulin in diabetic nephropathy

More Information
  • Received Date: March 19, 2019
  • Accepted Date: April 24, 2019
  • Available Online: February 22, 2021
  • Published Date: June 14, 2019
  •   Objective  To investigate the value of serum homocysteine, cystatin C, urinary albumin, and urinary β2 microglobulin in diabetic nephropathy.
      Methods  A total of 200 diabetic nephropathy patients in our hospital were randomly selected as research group. In the same period, 200 healthy subjects were selected as control group. Levels of serum homocysteine, cystatin C, urinary albumin, and urinary β2 microglobulin were detected in both groups, and the differences between the two groups were compared.
      Results  The serum homocysteine, cystatin C, urinary albumin, and urinary β2 microglobulin levels in the study group at diagnosis were higher than that in the control group at physical examination and after treatment(P < 0.05). The positive rate of combined detection of homocysteine, cystatin C, urinary albumin, and urinary β2 microglobulin was 89.00%, which was higher than 49.50%, 65.00%, 57.00%, and 67.50%, respectively, of detection alone(P < 0.05).
      Conclusion  Clinical combineddetection of serum homocysteine, cystatin C, urinary albumin, and urinary β2 microglobulin is helpful to improve the positive rate of diagnosis of diabetic nephropathy and guide the formulation of treatment plan.
  • [1]
    张洁, 张妮娅. 300例老年糖尿病患者临床流行病学特点及诊治分析[J]. 解放军预防医学杂志, 2018, 36(5): 609-612. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYX201805015.htm
    [2]
    孔晶, 邢小平. 糖尿病与骨质疏松症[J]. 临床内科杂志, 2016, 33(9): 585-588. doi: 10.3969/j.issn.1001-9057.2016.09.002
    [3]
    周婷, 刘祥, 李晓松, 等. 中国人群2型糖尿病影响因素的Meta分析[J]. 中华流行病学杂志, 2016, 37(5): 730-736. doi: 10.3760/cma.j.issn.0254-6450.2016.05.030
    [4]
    姚芳. 方水林名老中医治疗糖尿病肾病经验总结[J]. 中华中医药学刊, 2016, 34(5): 1162-1165. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201605044.htm
    [5]
    王强. 糖尿病肾病患者血清Cys C、Hcy和尿mindin、NAG含量检测及对疾病早期诊断的价值[J]. 海南医学院学报, 2016, 22(10): 980-983. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201610013.htm
    [6]
    韩秋霞, 郭佳, 刘章锁. 遗传因素在糖尿病肾病发病机制中的研究进展[J]. 中华肾脏病杂志, 2016, 32(12): 949-952. doi: 10.3760/cma.j.issn.1001-7097.2016.12.014
    [7]
    王帅, 韦芳. 糖尿病肾病患者肾功能检查的临床研究[J]. 临床检验杂志: 电子版, 2016, 5(3): 180-182. https://www.cnki.com.cn/Article/CJFDTOTAL-LNJI201603020.htm
    [8]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 64-67. doi: 10.3969/j.issn.1006-6187.2018.01.014
    [9]
    中华医学会糖尿病学分会微血管并发症学组. 糖尿病肾病防治专家共识(2014年版)[J]. 中国糖尿病杂志, 2014, 6(11): 792-801. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201601001.htm
    [10]
    王栋栋, 魏彤, 何素梅, 等. 西格列汀延缓或阻止2型糖尿病肾病进展的实验研究[J]. 中国临床药理学杂志, 2016, 32(1): 45-47, 54. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201601015.htm
    [11]
    闫永恒, 李渐鹏, 刘战伟, 等. 不同2型糖尿病肾病模型建立方法及成模特点比较[J]. 中国食物与营养, 2016, 22(1): 65-69. doi: 10.3969/j.issn.1006-9577.2016.01.015
    [12]
    陈伟, 田鲁, 李易, 等. 苦瓜总皂苷对2型糖尿病肾病大鼠肾脏组织中HIF-1α和VEGF表达的作用研究[J]. 环球中医药, 2016, 9(6): 659-663. doi: 10.3969/j.issn.1674-1749.2016.06.004
    [13]
    李爱琴, 匡霞, 林立平, 等. 2型糖尿病肾病患者尿脂联素与尿蛋白、血压及血糖的相关性[J]. 实用医学杂志, 2016, 32(20): 3310-3312. doi: 10.3969/j.issn.1006-5725.2016.20.007
    [14]
    张关亭. CysC、β2微球蛋白、肌酐、尿素氮在2型糖尿病肾病不同阶段的水平变化及诊断价值[J]. 中华全科医学, 2017, 15(5): 850-852. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201705038.htm
    [15]
    黄静, 常保超, 刘磊, 等. 糖尿病肾病与炎性细胞因子的研究现状[J]. 蚌埠医学院学报, 2016, 41(10): 1396-1399. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201610046.htm
    [16]
    戚文群, 史爱梅, 蒋泽, 等. 老年2型糖尿病患者血同型半胱氨酸与踝肱指数的关系[J]. 实用临床医药杂志, 2016, 20(9): 170-170, 173. doi: 10.7619/jcmp.201609060
    [17]
    陆璟园, 施丹晔, 余晨, 等. 联合检测血清同型半胱氨酸、胱抑素C对早期糖尿病肾病的诊断价值[J]. 陕西医学杂志, 2016, 45(12): 1681-1683. doi: 10.3969/j.issn.1000-7377.2016.12.054
    [18]
    李仲廷. 联合检测β2-微球蛋白和尿微量蛋白对糖尿病肾病早期诊断的临床意义[J]. 中国实验诊断学, 2017, 21(8): 1372-1374. doi: 10.3969/j.issn.1007-4287.2017.08.029
  • Related Articles

    [1]YIN Ying, GAO Yan, YANG Xiaoxin, MA Wenjing, WANG Wei. Application of family-involved nursing model under concept of rapid recovery in perioperative nursing for patients with pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 129-133. DOI: 10.7619/jcmp.20240679
    [2]LU Yanfeng, DAI Jiabao, WU Zhouquan, ZOU Zhiqing. Effect of esketamine on perioperative pain and depression in patients with thoracoscopic pulmonary nodule resection[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 90-94. DOI: 10.7619/jcmp.20234042
    [3]GAO Yan, WANG Wei, YANG Xiaoxin, DING Jiefang, YIN Ying. Precision nursing for patients with visualization technology assisted pulmonary nodule surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 97-100, 106. DOI: 10.7619/jcmp.20233596
    [4]LIN Weiyong, WENG Wenjun. Identification characteristic of benign and malignant pulmonary nodules and differential diagnostic indicators of the infiltration degree of malignant ground-glass nodules[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 14-19. DOI: 10.7619/jcmp.20232071
    [5]WEI Xinqi, RUAN Aichao, YANG Ying, ZHANG Qing. Clinical nursing pathway management in patients with CT-guided thoracoscopic small pulmonary nodules resection[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 120-123. DOI: 10.7619/jcmp.20221144
    [6]LI Juanjuan, LIU Min, YANG Bin, DU Wei, YANG Hongkai, LIAO Yanquan, LI Junhang, WANG Jun. Application of artificial intelligence-assisted pulmonary nodule screening and qualitative diagnosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 8-12. DOI: 10.7619/jcmp.20214698
    [7]CAO Lan, TAO Yujian, ZHAO Yuanlu, ZHANG Pan. Analysis in risk factors of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 38-40, 44. DOI: 10.7619/jcmp.20200457
    [8]LIU Desen, CHEN Xiaochun, ZHU Feng, LIU Yongjie, CHEN Ming, LIU Feng, MA Haitao. Clinical analysis in chest CT and pathology of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2018, (7): 96-98. DOI: 10.7619/jcmp.201807026
    [9]ZHONG Chonghao, SHI Hongcan, SHU Yusheng, SHI Weiping, LU Shichun, SUN Chao. Establishment and clinical verification of a mathematical model foRpredicting the probability of malignancy oRbegin in patients with solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2017, (9): 82-85,93. DOI: 10.7619/jcmp.201709021
    [10]XI Xiaoxiang, LYU Bihong, YE Ting, HE Guangming, CHEN Rui, XU Xiang, WANG Baoguan. Value of serum NSE, Cyfra21-1, CEA and CA125 in diagnosis of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2015, (21): 41-43,51. DOI: 10.7619/jcmp.201521011
  • Cited by

    Periodical cited type(23)

    1. 魏淑敏,陈岩,刘俊婷. 序贯肠内外营养支持辅助治疗急性脑卒中伴吞咽障碍临床观察. 社区医学杂志. 2024(02): 56-59 .
    2. 王子雪. 两种营养护理方案在重症脑梗死患者中的应用. 中国城乡企业卫生. 2024(03): 102-105 .
    3. 谢柏发,邓静,余刚. 早期肠内营养支持疗法在重症脑出血临床治疗中的效果及有效性分析. 基层医学论坛. 2024(10): 76-78+91 .
    4. 吴苑云,范子英,卓月凤. 重症脑出血患者围术期营养支持的现状及研究进展. 现代医学与健康研究电子杂志. 2024(06): 128-131 .
    5. 黄霞,张莉,狄红珍,冯小丹,朱梅. 早期序贯康复护理联合童趣化互动干预对外伤性颅内出血患儿的影响. 护理实践与研究. 2024(06): 821-827 .
    6. 张明,刘逸文,文章. 早期肠内营养乳剂支持疗法治疗重症脑出血患者的临床研究. 广东药科大学学报. 2024(05): 127-131 .
    7. 戴颖,龚丽. 重症脑出血患者应用ADOPT模式护理联合5A护理的效果. 医药前沿. 2024(15): 114-116 .
    8. 郑蕾. 序贯式肠内营养支持对重症脑出血患者营养状况及胃肠道喂养不耐受的影响. 内蒙古医学杂志. 2023(02): 247-249 .
    9. 黄玉琪,刘颖,石改红. ERAS理念指导的护理干预对前列腺增生患者术后康复的影响. 国际医药卫生导报. 2023(07): 1015-1020 .
    10. 任丽敏. 营养支持联合早期运动整合干预对重症脑出血患者早期预后的影响. 中国实用乡村医生杂志. 2023(03): 59-63 .
    11. 周琴,吴晓芳,王敏. 早期微生态肠内营养介入与管理在老年神经外科重症机械通气患者中的应用价值分析. 当代护士(中旬刊). 2023(05): 113-117 .
    12. 刘艳红,葛利越,杨静,蒋大丽. 基于快速康复外科理念的分阶段护理干预联合序贯性EEN与康复锻炼对胃癌患者预后的影响. 海军医学杂志. 2023(06): 646-648 .
    13. 李纲. 肠内营养序贯治疗对重症急性脑梗死合并吞咽功能障碍患者营养状态不良反应及并发症的影响. 中国药物与临床. 2022(02): 163-165 .
    14. 赵轶梁. 早期肠内外营养联合支持在重症脑卒中患者中的应用效果观察. 实用中西医结合临床. 2022(01): 70-71+78 .
    15. 崔益明,金守兵,陈彩霞. 早期肠内营养支持疗法在重症脑出血临床治疗中的效果. 吉林医学. 2022(04): 1044-1045 .
    16. 贾亚杰,姚明. 肠内营养支持与肠外营养支持序贯治疗危重患者的临床价值. 中国医药科学. 2022(11): 187-189+196 .
    17. 黄涵. 序贯性肠内营养在重症脑出血患者治疗中的应用效果分析. 中国社区医师. 2021(01): 20-21 .
    18. 王德荣. 围手术期序贯性肠内营养在肝段切除患者中的应用及护理. 中外医学研究. 2021(15): 179-181 .
    19. 王英华. 肠内营养支持结合个性化营养护理对原发性脑出血患者病情康复效果的影响. 中外医疗. 2021(21): 164-167+171 .
    20. 汪海滔,陈伟鹏,邓惠森. 序贯性肠内营养在重症脑出血患者治疗中的应用效果分析. 吉林医学. 2021(10): 2476-2477 .
    21. 杜欢,钱坤,姚淑芳. 序贯性早期肠内营养在重症脑出血患者中的应用效果. 中国民康医学. 2021(20): 39-41 .
    22. 庞春. 术后早期应用肠内营养治疗重症脑出血患者术后腹泻的效果. 中国医药指南. 2020(31): 70-71 .
    23. 冯二艳,罗书引,潘幸尧,郑红艳,丁宗励. 肠内序贯营养支持联合益生菌对重型颅脑损伤患者营养状况及胃肠功能障碍的改善作用研究. 解放军预防医学杂志. 2020(09): 127-130 .

    Other cited types(0)

Catalog

    Article views (316) PDF downloads (7) Cited by(23)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return